DealShot

DealShot: HG Capital Leads $38M Series C Round In Chinese Cancer Hospital Operator Kexin Health

Follow Us:
LinkedIn
Twitter
YouTube
Facebook
Weibo

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
Shenma FinanceSeries CChina Growth Capital, Hina Group, Tongbanjie GroupCredit Ease Financial Industry Investment Fund, ChinaEquity GroupTransportation & SpaceShanghai
Hunan Kexin Health Industry Development Co., LtdSeries CHG CapitalOriental Fortune CapitalHealthcareChangsha
H-VisionsSeries BRedpoint Ventures ChinaEnterprise ServicesShanghai
thecover.cnPre-ASichuan Cultural Industry Equity Investment FundMedia & EntertainmentSichuan
YimifudaoSeries BBluelake CapitalDivine CapitalEducationShanghai
Blacklake TechnologySeries A+Bertelsmann Asia Investments, GSR VenturesSoftware & InternetShanghai
SibuSeries BChina Growth CapitalE-commerceGuangzhou
Jenscare BiotechSeries ACDBI PartnersHealthcareNingbo
CentralCloudIVAngel RoundInnoangel FundTransportation & SpaceBeijing
LikechuxingSeries BAnt FinancialLegend Capital, K2VC, BlueRun VenturesTransportation & SpaceGuangzhou
TingjiandanSeries B+Ant FinancialSunsea ParkingTransportation & SpaceBeijing
North Ocean PhotonicsSeries A+Vision Plus Capital, CAS Star, Walden InternationalSmart HardwareShanghai
Sirtex MedicalPECDH InvestmentsHealthcareAustralia
China Better-LifeStrategic InvestmentYuwell MedicalHealthcareShanghai
AibeeStrategic InvestmentZhigang Zheng (K11's founder)AI & RoboticsBeijing
VSPNStrategic InvestmentTencent HoldingsGamingShanghai
KcashStrategic InvestmentGXS FoundationBlockchainBeijing
 


Related News








Leave a Reply

Your email address will not be published. Required fields are marked *